Basic Information
| ID | DRAMP21005 |
|---|
| Sequence | GCRALCYKQRCVTYCRGA |
|---|
| Length | 18 |
|---|
| Name | [R4A, R18A]cGm (Derived from Gm) |
|---|
| Source | Synthetic construct |
|---|
| Activity | Antimicrobial, Antibacterial, Anti-Gram+, Anti-Gram-, Antifungal, Antitumor |
|---|
| Pathogen | [Ref.28741926]Gram-positive bacteria : Staphylococcuss aureus ATCC 25923 (MIC=32 μM);##Gram-negative bacteria : Escherichia coli ATCC 25922 (MIC=8 μM), Escherichia coli CGSC 5167 (MIC=0.5-1 μM), Klebsiella pneumoniae ATCC 700603 (MIC=32 μM), Acinetobacter baumannii ATCC 19606 (MIC=8-16 μM), Pseudomonas aeruginosa ATCC 27853 (MIC=8 μM), Helicobacter pylori ATCC 43504 (MIC>80 μM);##Fungi : Candida albicans ATCC 90028 (MIC=32 μM), Cryptococcus neoformans ATCC 208821 (MIC=8-16 μM) |
|---|
| Hemolytic Activity | [Ref.28741926] 0% hemolysis at 17 μM , 3% hemolysis at 35 μM , 30-48.6% hemolysis at 64 μM , 40% hemolysis at 100 μM against human red blood cells |
|---|
| Cytotoxicity | [Ref.28741926] CC50 > 64 μM against CRL-1739, CC50 = 10.3 ± 1.1 μM against MM96L, CC50 = 51.2 ± 4.0 μM against HFF-1, CC50 > 64 μM against HeLa, CC50 = 48.4 ± 0.7 μM against MCF-7, CC50 = 11.5 ± 0.6 μM against K-562, CC50 = 34.1 ± 3.9 μM against HL-60;CC50=30.8 ± 2.5μM against PBMCs. |
|---|
| N-terminal Modification | No specific N-terminal |
|---|
| C-terminal Modification | No specific C-terminal |
|---|
| Linear/Cyclic/Branched | Cyclic |
|---|
| Uniprot |
|
|---|
| PDB |
|
|---|
| 3D View | |
|---|
| PDB Download | Download PDB Predicted by Alphafold2 |
|---|
| PubMed ID | 28741926 |
|---|
